185 related articles for article (PubMed ID: 12683719)
1. Targeting tumor vasculature: reality or a dream?
Satchi-Fainaro R
J Drug Target; 2002 Nov; 10(7):529-33. PubMed ID: 12683719
[No Abstract] [Full Text] [Related]
2. [Targeting blood vessels for treatment of cancer...].
Sonveaux P; Feron O
J Pharm Belg; 2003; 58(3):79-80. PubMed ID: 14619689
[No Abstract] [Full Text] [Related]
3. Aberrant tumor vasculature and angiogenesis: new opportunities for cancer therapy.
Zhu Z
Drug Discov Today; 2003 Sep; 8(18):827-8. PubMed ID: 12963316
[No Abstract] [Full Text] [Related]
4. Imaging tumor angiogenesis.
Red-Horse K; Ferrara N
J Clin Invest; 2006 Oct; 116(10):2585-7. PubMed ID: 17016553
[TBL] [Abstract][Full Text] [Related]
5. Vascular Detransformation for Cancer Therapy.
Fan Y
Trends Cancer; 2019 Aug; 5(8):460-463. PubMed ID: 31421902
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.
Ranieri G; Gasparini G
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):241-53. PubMed ID: 12477290
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.
Bikfalvi A; Bicknell R
Trends Pharmacol Sci; 2002 Dec; 23(12):576-82. PubMed ID: 12457776
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascularization in tumor growth.
Scalerandi M; Sansone BC
Phys Rev Lett; 2002 Nov; 89(21):218101. PubMed ID: 12443451
[TBL] [Abstract][Full Text] [Related]
9. Escape mechanisms after antiangiogenic treatment, or why are the tumors growing again?
Hlushchuk R; Makanya AN; Djonov V
Int J Dev Biol; 2011; 55(4-5):563-7. PubMed ID: 21858777
[TBL] [Abstract][Full Text] [Related]
10. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
11. The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents.
Siemann DW
Cancer Treat Rev; 2011 Feb; 37(1):63-74. PubMed ID: 20570444
[TBL] [Abstract][Full Text] [Related]
12. Can mosaic tumor vessels facilitate molecular diagnosis of cancer?
Folkman J
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):398-400. PubMed ID: 11209044
[No Abstract] [Full Text] [Related]
13. Liposomal targeting of angiogenic vasculature.
Schiffelers RM; Fens MH; Janssen AP; Molema G; Storm G
Curr Drug Deliv; 2005 Oct; 2(4):363-8. PubMed ID: 16305439
[TBL] [Abstract][Full Text] [Related]
14. The role of tumor oxygenation in vascular and clinical response to angiogenesis inhibition.
Gee MS; Lee WM
Adv Exp Med Biol; 2003; 510():1-5. PubMed ID: 12580396
[No Abstract] [Full Text] [Related]
15. Can tumor angiogenesis be inhibited without resistance?
Miller KD; Sweeney CJ; Sledge GW
EXS; 2005; (94):95-112. PubMed ID: 15617473
[No Abstract] [Full Text] [Related]
16. Tumor vasculature: a sally port for inhibiting cancer cell spreading.
Qian CN; Pezzella F
Cancer Commun (Lond); 2018 Aug; 38(1):52. PubMed ID: 30075743
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of the tumor vasculature.
Tozer GM; Bicknell R
Semin Radiat Oncol; 2004 Jul; 14(3):222-32. PubMed ID: 15254865
[TBL] [Abstract][Full Text] [Related]
18. Current overview of angiogenesis inhibitors.
Ellis LM
Clin Adv Hematol Oncol; 2004 Aug; 2(8):494-6, 520. PubMed ID: 16163228
[No Abstract] [Full Text] [Related]
19. Angiogenesis inhibitors and radiotherapy of primary tumours.
Camphausen K; Menard C
Expert Opin Biol Ther; 2002 Jun; 2(5):477-81. PubMed ID: 12079484
[TBL] [Abstract][Full Text] [Related]
20. Written in the blood.
Lewis R
Nature; 2006 Mar; 440(7084):710-1. PubMed ID: 16637100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
